209 related articles for article (PubMed ID: 20822536)
1. Large-scale data integration framework provides a comprehensive view on glioblastoma multiforme.
Ovaska K; Laakso M; Haapa-Paananen S; Louhimo R; Chen P; Aittomäki V; Valo E; Núñez-Fontarnau J; Rantanen V; Karinen S; Nousiainen K; Lahesmaa-Korpinen AM; Miettinen M; Saarinen L; Kohonen P; Wu J; Westermarck J; Hautaniemi S
Genome Med; 2010 Sep; 2(9):65. PubMed ID: 20822536
[TBL] [Abstract][Full Text] [Related]
2. Data integration workflow for search of disease driving genes and genetic variants.
Karinen S; Heikkinen T; Nevanlinna H; Hautaniemi S
PLoS One; 2011 Apr; 6(4):e18636. PubMed ID: 21533266
[TBL] [Abstract][Full Text] [Related]
3. Integrative platform to translate gene sets to networks.
Laakso M; Hautaniemi S
Bioinformatics; 2010 Jul; 26(14):1802-3. PubMed ID: 20507894
[TBL] [Abstract][Full Text] [Related]
4. Anduril 2: upgraded large-scale data integration framework.
Cervera A; Rantanen V; Ovaska K; Laakso M; Nuñez-Fontarnau J; Alkodsi A; Casado J; Facciotto C; Häkkinen A; Louhimo R; Karinen S; Zhang K; Lavikka K; Lyly L; Pal Singh M; Hautaniemi S
Bioinformatics; 2019 Oct; 35(19):3815-3817. PubMed ID: 30793160
[TBL] [Abstract][Full Text] [Related]
5. CNAmet: an R package for integrating copy number, methylation and expression data.
Louhimo R; Hautaniemi S
Bioinformatics; 2011 Mar; 27(6):887-8. PubMed ID: 21228048
[TBL] [Abstract][Full Text] [Related]
6. Discovering gene-environment interactions in glioblastoma through a comprehensive data integration bioinformatics method.
Kunkle B; Yoo C; Roy D
Neurotoxicology; 2013 Mar; 35():1-14. PubMed ID: 23261424
[TBL] [Abstract][Full Text] [Related]
7. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
Chen X; Pan Y; Yan M; Bao G; Sun X
Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme.
Han J; Puri RK
J Neurooncol; 2018 Feb; 136(3):463-474. PubMed ID: 29168083
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of glioblastoma multiforme versus anaplastic astrocytoma identifies robust gene markers.
Dreyfuss JM; Johnson MD; Park PJ
Mol Cancer; 2009 Sep; 8():71. PubMed ID: 19732454
[TBL] [Abstract][Full Text] [Related]
10. Integrative analysis of micro-RNA, gene expression, and survival of glioblastoma multiforme.
Huang YT; Hsu T; Kelsey KT; Lin CL
Genet Epidemiol; 2015 Feb; 39(2):134-43. PubMed ID: 25537983
[TBL] [Abstract][Full Text] [Related]
11. Exploratory analysis of the copy number alterations in glioblastoma multiforme.
Freire P; Vilela M; Deus H; Kim YW; Koul D; Colman H; Aldape KD; Bogler O; Yung WK; Coombes K; Mills GB; Vasconcelos AT; Almeida JS
PLoS One; 2008; 3(12):e4076. PubMed ID: 19115005
[TBL] [Abstract][Full Text] [Related]
12. A systematic review of overall survival in pediatric primary glioblastoma multiforme of the spinal cord.
Konar SK; Bir SC; Maiti TK; Nanda A
J Neurosurg Pediatr; 2017 Feb; 19(2):239-248. PubMed ID: 27813458
[TBL] [Abstract][Full Text] [Related]
13. Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients.
Gao WZ; Guo LM; Xu TQ; Yin YH; Jia F
J Transl Med; 2018 Dec; 16(1):368. PubMed ID: 30572911
[TBL] [Abstract][Full Text] [Related]
14. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.
Silber J; Lim DA; Petritsch C; Persson AI; Maunakea AK; Yu M; Vandenberg SR; Ginzinger DG; James CD; Costello JF; Bergers G; Weiss WA; Alvarez-Buylla A; Hodgson JG
BMC Med; 2008 Jun; 6():14. PubMed ID: 18577219
[TBL] [Abstract][Full Text] [Related]
15. A Systemic Analysis of Transcriptomic and Epigenomic Data To Reveal Regulation Patterns for Complex Disease.
Xu C; Zhang JG; Lin D; Zhang L; Shen H; Deng HW
G3 (Bethesda); 2017 Jul; 7(7):2271-2279. PubMed ID: 28500050
[TBL] [Abstract][Full Text] [Related]
16. Glioblastoma multiforme - an overview.
Urbańska K; Sokołowska J; Szmidt M; Sysa P
Contemp Oncol (Pozn); 2014; 18(5):307-12. PubMed ID: 25477751
[TBL] [Abstract][Full Text] [Related]
17. Identification of Novel Transcriptome Signature as a Potential Prognostic Biomarker for Anti-Angiogenic Therapy in Glioblastoma Multiforme.
Zheng S; Tao W
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33804433
[TBL] [Abstract][Full Text] [Related]
18. Multi-Omics Data Integration and Mapping of Altered Kinases to Pathways Reveal Gonadotropin Hormone Signaling in Glioblastoma.
Jayaram S; Gupta MK; Raju R; Gautam P; Sirdeshmukh R
OMICS; 2016 Dec; 20(12):736-746. PubMed ID: 27930095
[TBL] [Abstract][Full Text] [Related]
19. IndividualizedPath: identifying genetic alterations contributing to the dysfunctional pathways in glioblastoma individuals.
Ping Y; Zhang H; Deng Y; Wang L; Zhao H; Pang L; Fan H; Xu C; Li F; Zhang Y; Gong Y; Xiao Y; Li X
Mol Biosyst; 2014 Aug; 10(8):2031-42. PubMed ID: 24911613
[TBL] [Abstract][Full Text] [Related]
20. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
